Amarin stock tanks nearly 70% after losing a patent battle over its key heart drug

The United States District Court of Nevada on Monday ruled that Amarin's patent claims for Vascepa, a heart drug that uses fish oil to lower triglycerides, ... Read more

Bron:

Business Insider India